Company intelligence / Profile preview

Kinled

Hong Kong, Hong Kong

Ownership: Private
Development stage: Other

Overview

Kinled is not a drug developer but a family-owned investment holding company and venture investor focused heavily on life sciences, medtech, biotech, neuromodulation, and digital health, with more than half of its portfolio in these sectors.[2][3]

Industry: Investors

Partnerships

T45 Labs (cardiovascular medtech incubator partnership and investment in its fund)[1]Cebina (Central European Biotech Incubator & Accelerator, founding/anchor partner)[2]Danube BioVentures (venture funds for drug development and biomedical innovation)[2][4]Multiple life science and digital technology venture funds in Vienna, Zurich, London/Copenhagen, Prague/Bratislava, and Helsinki as founding partner/LP[2][4]

Beyond the preview

Go deeper on Kinled.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kinled.

Explore the full profile